⌕
Corcept Therapeutics · CORT · Nasdaq
Tenet 54 · Mixed
Compare
$70.07+1.23%At closeTenet 54 · Mixed
$70.07+0.85 (+1.23%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Corcept Therapeutics (CORT) Institutional Ownership

13F filers reported holding 75.3% of Corcept Therapeutics (CORT) shares as of Sep 30, 2026, across 503 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
75.3%
Sep 30, 2026
13F filers
503
quarter ended Sep 30, 2026
13F value
$9.5B
82.5M shares
Quarter's fund flow
Mild accumulation
122 new · 37 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (122 new · 172 increased · 151 reduced · 37 closed · 21 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 503 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 10, 2026Swisher Daniel N JRdirectorAcquired · Option exercise1,100$14.08↗
Nov 10, 2026Swisher Daniel N JRdirectorAcquired · Option exercise400$10.50↗
Nov 10, 2026Swisher Daniel N JRdirectorDisposed · Open-market sale1,500$74.07↗
Nov 10, 2026Swisher Daniel N JRdirectorDisposed · Option exercise1,100Stock Option (right to buy)—↗
Nov 10, 2026Swisher Daniel N JRdirectorDisposed · Option exercise400Stock Option (right to buy)—↗
Nov 3, 2026Maduck SeanotherAcquired · Option exercise13,159$8.27↗
Nov 3, 2026Maduck SeanotherDisposed · Open-market sale8,617$82.02↗
Nov 3, 2026Maduck SeanotherDisposed · Open-market sale4,542$82.68↗
Nov 3, 2026Maduck SeanotherDisposed · Option exercise13,159Stock option (right to buy)—↗
Nov 2, 2026Maduck SeanotherAcquired · Option exercise11,841$8.27↗
Nov 2, 2026Maduck SeanotherDisposed · Open-market sale11,841$81.42↗
Nov 2, 2026Maduck SeanotherDisposed · Option exercise11,841Stock option (right to buy)—↗
Nov 2, 2026Vieira Roberto WandenkolkPresident, OncologyAcquired · Option exercise8,333$21.63↗
Nov 2, 2026Vieira Roberto WandenkolkPresident, OncologyDisposed · Open-market sale6,657$80.73↗
Nov 2, 2026Vieira Roberto WandenkolkPresident, OncologyDisposed · Open-market sale1,676$81.52↗
Nov 2, 2026Vieira Roberto WandenkolkPresident, OncologyDisposed · Option exercise8,333Stock option (right to buy)—↗
Oct 15, 2026WILSON JAMES NdirectorDisposed · Open-market sale6,654$114.48↗
Oct 15, 2026WILSON JAMES NdirectorDisposed · Open-market sale3,046$115.39↗
Oct 15, 2026WILSON JAMES NdirectorDisposed · Open-market sale300$116.30↗
Oct 2, 2026Vieira Roberto WandenkolkPresident, OncologyAcquired · Option exercise8,333$21.63↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Corcept Therapeutics do institutions hold?

13F filers reported holding 75.3% of Corcept Therapeutics' shares as of Sep 30, 2026, across 503 filers.

How many 13F filers hold Corcept Therapeutics?

Corcept Therapeutics was held by 503 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.